Cordarone Extravasation Inducing Volkmann's-like Syndrome
Paolo Simoni1, Laura Scarciolla2, Carole Maréchal1
1Service of MSK imaging, University Hospital of Liege (CHU), Domain du Sart Tilman Bat. 45, 4000-B Liege, Belgium.
This case study details a rare instance of Volkmann's-like syndrome following cordarone extravasation. The event led to severe soft tissue necrosis and upper limb retraction, highlighting a critical adverse effect of this cardiac medication.
Area of Science:
- Cardiology
- Vascular Surgery
- Pharmacology
Background:
- Cordarone (amiodarone) is a critical medication for managing cardiac arrhythmias.
- Extravasation of intravenous medications can lead to severe local tissue damage.
- Volkmann's ischemic contracture is a serious complication typically associated with forearm fractures.
Observation:
- A patient developed Volkmann's-like syndrome after extravasation of 300 mg of cordarone during cardiac arrest treatment.
- Extensive skin and soft tissue necrosis of the forearm was observed the day after the extravasation.
- Progressive muscle retraction in the forearm indicated developing contracture.
Findings:
- This is the first reported case of acute soft tissue necrosis causing Volkmann's-like upper limb retraction after cordarone extravasation.
- Imaging studies confirmed the extent of tissue damage and muscular involvement.
- Literature review indicates limited data on amiodarone-induced extravasation complications.
Implications:
- Clinicians should be aware of the potential for severe local tissue injury from cordarone extravasation.
- Prompt recognition and management of cordarone extravasation are crucial to prevent irreversible limb damage.
- This case underscores the importance of careful drug administration techniques and monitoring for adverse events.
More Related Videos
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
07:41Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Dysrhythmias VI: Management of Dysrhythmias
Heart Failure Drugs: Inotropic Agents
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
